TUPELO Trial: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of REC-4881 in Subjects With Familial Adenomatous Polyposis (FAP): Study Design